Target intelligence / Profile preview

PHKA2 antisense RNA 1 (PHKA2-AS1)

Target: PHKA2-AS1
Molecular classification: Long non-coding RNA (lncRNA)

Overview

PHKA2 antisense RNA 1 (PHKA2-AS1) is a human long non-coding RNA gene transcribed from the opposite strand of the PHKA2 gene. It does not encode a protein but may regulate PHKA2 or other genes via antisense mechanisms or other lncRNA-associated pathways. PHKA2-AS1 has been found to be differentially expressed in certain cancers, suggesting a possible regulatory or biomarker role. There is no evidence that it is a classical drug target, enzyme, transporter, or receptor, and its molecular functions and clinical significance remain the subject of ongoing research

Mechanism of action

Not established for drugs, as PHKA2-AS1 is not a therapeutic target

Biological functions

Regulation of gene expression (exact function not definitively established; general lncRNA roles include chromatin remodeling, transcriptional and post-transcriptional modulation)

Disease associations

Cancer (differential expression reported in breast cancer and potentially other cancers)Glycogen storage diseases association due to proximity to PHKA2 gene, but no direct pathogenic role firmly established

Safety considerations

None reported; there are no therapies targeting PHKA2-AS1, so therapeutic risks are unknown

Biomarkers

Investigated as a potential biomarker for cancer, particularly through gene expression profiling in breast cancer; more research required for validation

Beyond the preview

Go deeper on PHKA2 antisense RNA 1 (PHKA2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHKA2 antisense RNA 1 (PHKA2-AS1).

Explore the full profile